Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic
- PMID: 24410
- PMCID: PMC352183
- DOI: 10.1128/AAC.13.1.49
Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic
Abstract
Cefaclor solutions in pH 2.5 and 4.5 buffers contained at least 90% of their initial activity after 72 h at 4 degrees C. Samples in pH 6.0, 7.0, and 8.0 buffers contained 70, 46, and 34%, respectively, of their initial activity after 72 h at 4 degrees C. After 72 h at 25 degrees C, samples prepared with pH 2.5, 4.5, 6.0, 7.0, and 8.0 buffers contained 95, 69, 16, 5, and 3%, respectively, of their initial activity. After 72 h at 37 degrees C, cefaclor solutions in pH 2.5 buffer contained 80% of the initial activity, whereas samples prepared in pH 4.5, 6.0, 7.0, and 8.0 buffers contained less than 20%. Laboratory-prepared plasma and serum samples showed an 8% loss in activity when incubated for 6 h at 4 degrees C, a 51% loss when incubated for 6 h at 25 degrees C, and a 48% loss when incubated for 2 h at 37 degrees C. Clinical samples demonstrated a similar stability pattern. Degradation rates for cefaclor in commercially prepared serum increased from 4- to 10-fold in comparison to rates obtained when samples were made in human serum freshly prepared in our laboratory. Consequently, serum standards should be made in freshly prepared human serum.
Similar articles
-
Influence of temperature on degradation kinetics of ceftriaxone in diluted and undiluted human serum.Antimicrob Agents Chemother. 1990 Jun;34(6):1268-70. doi: 10.1128/AAC.34.6.1268. Antimicrob Agents Chemother. 1990. PMID: 2393289 Free PMC article.
-
Pharmaceutical properties of loracarbef: the remarkable solution stability of an oral 1-carba-1-dethiacephalosporin antibiotic.Pharm Res. 1992 Feb;9(2):250-4. doi: 10.1023/a:1018949709797. Pharm Res. 1992. PMID: 1553350
-
[Assay of cefaclor in serum and urine (including stability test) using high pressure liquid chromatography (author's transl)].Infection. 1979;7 Suppl 6:603-5. doi: 10.1007/BF01659746. Infection. 1979. PMID: 551087 German.
-
Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions.J Pharm Sci. 1998 Dec;87(12):1572-6. doi: 10.1021/js980170y. J Pharm Sci. 1998. PMID: 10189269
-
Pharmacokinetic profile of cefaclor.Int J Clin Pharmacol Ther. 1997 Sep;35(9):374-80. Int J Clin Pharmacol Ther. 1997. PMID: 9314090 Review.
Cited by
-
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.J Clin Microbiol. 1988 Apr;26(4):770-3. doi: 10.1128/jcm.26.4.770-773.1988. J Clin Microbiol. 1988. PMID: 3259247 Free PMC article.
-
In vitro activities of LY163892, cefaclor, and cefuroxime.Antimicrob Agents Chemother. 1988 Jan;32(1):131-3. doi: 10.1128/AAC.32.1.131. Antimicrob Agents Chemother. 1988. PMID: 3348605 Free PMC article.
-
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.Antimicrob Agents Chemother. 1990 Jun;34(6):1204-9. doi: 10.1128/AAC.34.6.1204. Antimicrob Agents Chemother. 1990. PMID: 2393282 Free PMC article. Clinical Trial.
-
Pharmacokinetics of cefaclor in patients with end stage renal disease and during hemodialysis.Antimicrob Agents Chemother. 1978 Sep;14(3):281-3. doi: 10.1128/AAC.14.3.281. Antimicrob Agents Chemother. 1978. PMID: 708006 Free PMC article.
-
[Comparative study of cefaclor versus amoxicillin in urinary tract infections (author's transl)].Infection. 1979;7 Suppl 6:617-21. doi: 10.1007/BF01659750. Infection. 1979. PMID: 399250 Clinical Trial. German.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases